Hgh prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia

Abstract

Seventy-two patients with antiphospholipid antibodies (aPL), with or without antiphospholipid syndrome (APS), were studied for detection of heparin-PF4-induced antibodies (HPIA) using a commercial kit (Asserachrom^® HPIA) PF4-dependant enzyme-linked immunoassay (ELISA) test. None of the patients had a medical history of heparin induced thrombocytopenia (HIT). Eleven percent of patients were positive for HPIA. Plasma from 40 of the 72 patients (seven positive and 33 negative), was also tested with the other available HPIA ELISA (GTI^®) kit. Five patients were positive with both ELISA kits, two were highly positive only with Asserachrom^® HPIA and four only with GTI^®. None of the positive patients had severe thrombocytopenia. Two patients have never received heparin treatment. No relationship was found between HPIA presence and patients' age, sex, aPL levels or presence of lupus anticoagulant. No significant difference in HPIA presence was observed in patients with primary APS, secondary APS or aPL without APS. We found a poor correlation between the two commercial ELISA showing that, on the same blood sample, a patient could be highly positive with one technique and negative with the other. The PF4-dependant enzyme-linked immunoassay, which is often the first test used for the diagnosis of HIT, should be interpreted cautiously in patients with aPL since there is a danger of overdiagnosis and overtreatment.

Keywords

antiphospholipid antibodies antiphospholipid syndrome heparin induced thrombocytopenia heparin-PF4-induced antibodies

Get full access to this article

View all access options for this article.

References

Warkentin TE . New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest 2005; 127: 35–45.

Greinacher A, Warkentin TE . Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update. Thromb Res 2006; 118:165–176.

Francis JL . A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex. Semin Thromb Hemost 2004; 30: 359–368.

Levine JS , Branch DW , Rauch J . The antiphospholipid syndrome. N Engl J Med 2002; 346: 752–763.

Lasne D , Saffroy R , Bachelot C et al. Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndrome. Br J Haematol 1997; 97: 939–939.

Martinuzzo ME , Forastiero RR , Adamczuk Y , Pombo G , Carreras LO . Antiplatelet factor 4-heparin antibodies in patients with antiphospholipid antibodies. Thromb Res 1999; 95: 271–279.

de Larranaga G , Martinuzzo M , Bocassi A , Fressart MM , Forastiero R . Heparin-platelet factor 4 induced antibodies in patients with either autoimmune or alloimmune antiphospholipid antibodies. Thromb Haemost 2002; 88: 371–373.

Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309–1311.

Brandt JT , Triplett DA , Alving B , Scharrer I . Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus. Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185–1190.

10.

Harris EN , Pierangeli S , Birch D . Anticardiolipin wet workshop report. Fifth International Symposium on antiphospholipid antibodies. Am J Clin Pathol 1994; 101: 616–624.

11.

Miyakis S , Lockshin MD , Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306.

12.

Amiral J , Bridey F , Dreyfus M et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68: 95–96.

13.

Visentin GP , Moghaddam M , Beery SE , McFarland JG , Aster RH . Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis. J Lab Clin Med 2001; 138: 22–31.

14.

Chong BH , Burgess J , Ismail F . The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993; 69: 344–350.

15.

Arnout J . The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost 1996; 75: 536–541.